Table 1 Comparison of clinical data between the control group and the hyperuricemia group [n (%), \(\overline{x }\) ± s, M (Q1, Q3)].
Clinical factor | Control Group (n = 146) | Hyperuricemia Group (n = 55) | t/χ2/Z | P-value |
|---|---|---|---|---|
Sex | ||||
M | 89 (61.0) | 37 (67.3) | 0.681 | 0.409 |
F | 57 (39.0) | 18 (32.7) | ||
Age (years old) | 48.97 ± 11.57 | 50.09 ± 9.79 | − 0.636 | 0.526 |
Serum uric acid level (μmol/L) | 326.57 ± 59.19 | 459.16 ± 41.15 | − 17.92 | < 0.001 |
Glomerular ischemic lesion | ||||
Yes | 38 (26.0) | 38 (69.1) | 31.51 | < 0.001 |
No | 108 (74.0) | 17 (30.9) | ||
Hemoglobin (g/L) | 135.70 ± 15.95 | 136.08 ± 15.66 | − 0.150 | 0.081 |
Serum albumin (g/L) | 23.71 ± 5.48 | 26.49 ± 5.40 | − 3.215 | 0.002 |
Serum creatinine (μmol/L) | 65.62 ± 13.87 | 67.82 ± 12.91 | − 1.021 | 0.308 |
eGFR [ mL/(min.1.73m2)] | 107.32 ± 10.49 | 105.20 ± 9.36 | 1.309 | 0.192 |
Proteinuria (g/24 h) | 5.437 (3.465, 7.954) | 5.092 (3.125, 7.543) | − 0.937 | 0.349 |
Hypertension | ||||
Yes | 59 (40.7) | 33 (60.0) | 5.986 | 0.014 |
No | 86 (59.3) | 22 (40.0) | ||
TC (mmol/L) | 6.93 (5.65, 8.67) | 7.76 (6.22, 9.40) | − 1.844 | 0.065 |
TG (mmol/L) | 1.95 (1.49, 2.62) | 2.1 (1.43, 2.97) | − 0.976 | 0.329 |
LDL (mmol/L) | 4.57 (3.51, 5.76) | 5.29 (3.72, 6.78) | − 2.262 | 0.024 |
